Data as of Jul 31
| -0.06 / -1.20%|
The 1 analysts offering 12-month price forecasts for Nymox Pharmaceutical Corp have a median target of 9.50, with a high estimate of 9.50 and a low estimate of 9.50. The median estimate represents a +91.92% increase from the last price of 4.95.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.